- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
21
Companies with a Value score of at least 3, ordered by Value score
21 companies
Gilead Sciences
Market Cap: AR$172.3b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$56,600.00
7D
5.4%
1Y
47.7%
Amgen
Market Cap: US$226.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$14.40
7D
1.1%
1Y
54.3%
Bristol-Myers Squibb
Market Cap: AR$132.0b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$34,720.00
7D
3.3%
1Y
65.9%
Bristol-Myers Squibb
Market Cap: US$132.0b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$23.00
7D
0.7%
1Y
50.8%
Bayer
Market Cap: AR$47.9b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
AR$31,100.00
7D
n/a
1Y
n/a
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$6.86
7D
-3.2%
1Y
n/a
GSK
Market Cap: US$74.2b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$12.87
7D
-4.6%
1Y
30.9%
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,230.00
7D
-4.1%
1Y
n/a
GSK
Market Cap: AR$74.2b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$19,540.00
7D
-3.1%
1Y
51.8%
Gilead Sciences
Market Cap: US$172.3b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$37.26
7D
7.8%
1Y
24.2%
Biogen
Market Cap: AR$30.9b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$25,360.00
7D
2.3%
1Y
83.1%
AstraZeneca
Market Cap: AR$183.1b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$63,225.00
7D
0.5%
1Y
22.4%
Tempus AI
Market Cap: AR$9.3b
Operates as a healthcare technology company in the United States.
TEM
AR$6,500.00
7D
-11.4%
1Y
-18.3%
Biogen
Market Cap: US$30.9b
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$16.99
7D
1.0%
1Y
72.3%
Amgen
Market Cap: AR$226.7b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$22,410.00
7D
2.8%
1Y
74.4%
Vertex Pharmaceuticals
Market Cap: AR$130.7b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTX
AR$8,270.00
7D
-0.06%
1Y
64.7%
Novartis
Market Cap: US$234.5b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$39.45
7D
-1.4%
1Y
34.6%
Novartis
Market Cap: AR$238.7b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$61,075.00
7D
-0.3%
1Y
49.8%
Vertex Pharmaceuticals
Market Cap: US$130.7b
Operates as a biotechnology company in the United States, Europe, and internationally.
VRTXD
US$5.40
7D
-2.0%
1Y
40.4%
Tempus AI
Market Cap: US$9.3b
Operates as a healthcare technology company in the United States.
TEMD
US$4.51
7D
-5.3%
1Y
-25.3%
AstraZeneca
Market Cap: US$183.1b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$41.54
7D
0.8%
1Y
4.6%